Company / Share Buybacks
Fulgent Genetics, Inc. Share Buybacks History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Share Buybacks
$10.9M
FY2025
5-year range
$225.0K / $74.3M
FY2021-FY2025
Trend
+4737.3%
vs FY2024
Sector context
#77 of 101
Health Care
What the data says
Share Buybacks changed +4737% YoY in FY2025, a notable deviation from the 6-year average annual change of +20755%.
Based on SEC 10-K filings.
$11M in FY2025 with a 5-year CAGR of +181.1%.
Declined from $74M to $11M over the past 2 years.
Health Care sector context is included.
Share Buybacks over time
Growth rates
- 3-Year CAGR
- -47.3%
- 5-Year CAGR
- +181.1%
- 10-Year CAGR
- -
Sector benchmark
Bottom 24% in Health CareTop 76% of 101This company $10.9M Sector average $571.4M
▼
-98.1% below sector average
Key checks
Key Insights
- 5-year CAGR of +181.1%, indicating consistent growth.
- In FY2025, share buybacks increased 4737.3% year-over-year.
- Ranks #77 out of 101 companies in the Health Care sector.
- Peak share buybacks was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score 5.28 (safe zone, above 2.9 threshold)
- Negative profit margin: -15.1%
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Share BuybacksValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $10.9M | +4737.3% |
| FY2024 | $225.0K | -99.7% |
| FY2023 | $74.3M | +0.0% |
| FY2022 | $74.3M | - |
| FY2021 | - | - |
| FY2020 | $62.0K | +195.2% |
| FY2019 | $21.0K | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | $12.0M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026